 | • レポートコード：MRC2-11QY05950 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は顔用注射剤のグローバル市場について調査・分析したレポートです。種類別（ボトックス、皮膚充填剤、その他）市場規模、用途別（病院、クリニック、化粧品センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別顔用注射剤の競争状況、市場シェア ・世界の顔用注射剤市場：種類別市場規模 2015年-2020年（ボトックス、皮膚充填剤、その他） ・世界の顔用注射剤市場：種類別市場規模予測 2021年-2026年（ボトックス、皮膚充填剤、その他） ・世界の顔用注射剤市場：用途別市場規模 2015年-2020年（病院、クリニック、化粧品センター、その他） ・世界の顔用注射剤市場：用途別市場規模予測 2021年-2026年（病院、クリニック、化粧品センター、その他） ・北米の顔用注射剤市場分析：米国、カナダ ・ヨーロッパの顔用注射剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの顔用注射剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の顔用注射剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの顔用注射剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Merz Aesthetics、Prollenium Medical Technologies、Bloomega BioTechnology、Galderma、Ipsen Group、Suneva Medical、Polymekon、Visionmed、Syneron、Medytox、AQTIS Medical、ColBar LifeScience、SciVision Biotech、Hangzhou Techderm Biological Products、Qufu Guanglong Biochem ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.
In terms of geographical regions, the Americas will be the major market contributor throughout the next few years. The US is the major revenue contributor in this region, where rapid advances in technology, the increasing awareness about aesthetic procedures, and the increasing demand for minimally invasive techniques, will bolster the market’s growth prospects.
Market Analysis and Insights: Global Facial Injectables Market
The global Facial Injectables market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Facial Injectables Scope and Market Size
Facial Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Facial Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Facial Injectables market is segmented into
Botox
Dermal Fillers
Other
Segment by Application, the Facial Injectables market is segmented into
Hospitals
Clinics
Cosmetic Centers
Other
Regional and Country-level Analysis
The Facial Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Facial Injectables market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Facial Injectables Market Share Analysis
Facial Injectables market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Facial Injectables business, the date to enter into the Facial Injectables market, Facial Injectables product introduction, recent developments, etc.
The major vendors covered:
Allergan
Merz Aesthetics
Prollenium Medical Technologies
Bloomega BioTechnology
Galderma
Ipsen Group
Suneva Medical
Polymekon
Visionmed
Syneron
Medytox
AQTIS Medical
ColBar LifeScience
SciVision Biotech
Hangzhou Techderm Biological Products
Qufu Guanglong Biochem
1 Study Coverage
1.1 Facial Injectables Product Introduction
1.2 Market Segments
1.3 Key Facial Injectables Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Facial Injectables Market Size Growth Rate by Type
1.4.2 Botox
1.4.3 Dermal Fillers
1.4.4 Other
1.5 Market by Application
1.5.1 Global Facial Injectables Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cosmetic Centers
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Facial Injectables Market Size, Estimates and Forecasts
2.1.1 Global Facial Injectables Revenue 2015-2026
2.1.2 Global Facial Injectables Sales 2015-2026
2.2 Global Facial Injectables, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Facial Injectables Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Facial Injectables Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Facial Injectables Competitor Landscape by Players
3.1 Facial Injectables Sales by Manufacturers
3.1.1 Facial Injectables Sales by Manufacturers (2015-2020)
3.1.2 Facial Injectables Sales Market Share by Manufacturers (2015-2020)
3.2 Facial Injectables Revenue by Manufacturers
3.2.1 Facial Injectables Revenue by Manufacturers (2015-2020)
3.2.2 Facial Injectables Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Facial Injectables Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Facial Injectables Revenue in 2019
3.2.5 Global Facial Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Facial Injectables Price by Manufacturers
3.4 Facial Injectables Manufacturing Base Distribution, Product Types
3.4.1 Facial Injectables Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Facial Injectables Product Type
3.4.3 Date of International Manufacturers Enter into Facial Injectables Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Facial Injectables Market Size by Type (2015-2020)
4.1.1 Global Facial Injectables Sales by Type (2015-2020)
4.1.2 Global Facial Injectables Revenue by Type (2015-2020)
4.1.3 Facial Injectables Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Facial Injectables Market Size Forecast by Type (2021-2026)
4.2.1 Global Facial Injectables Sales Forecast by Type (2021-2026)
4.2.2 Global Facial Injectables Revenue Forecast by Type (2021-2026)
4.2.3 Facial Injectables Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Facial Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Facial Injectables Market Size by Application (2015-2020)
5.1.1 Global Facial Injectables Sales by Application (2015-2020)
5.1.2 Global Facial Injectables Revenue by Application (2015-2020)
5.1.3 Facial Injectables Price by Application (2015-2020)
5.2 Facial Injectables Market Size Forecast by Application (2021-2026)
5.2.1 Global Facial Injectables Sales Forecast by Application (2021-2026)
5.2.2 Global Facial Injectables Revenue Forecast by Application (2021-2026)
5.2.3 Global Facial Injectables Price Forecast by Application (2021-2026)
6 North America
6.1 North America Facial Injectables by Country
6.1.1 North America Facial Injectables Sales by Country
6.1.2 North America Facial Injectables Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Facial Injectables Market Facts & Figures by Type
6.3 North America Facial Injectables Market Facts & Figures by Application
7 Europe
7.1 Europe Facial Injectables by Country
7.1.1 Europe Facial Injectables Sales by Country
7.1.2 Europe Facial Injectables Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Facial Injectables Market Facts & Figures by Type
7.3 Europe Facial Injectables Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Facial Injectables by Region
8.1.1 Asia Pacific Facial Injectables Sales by Region
8.1.2 Asia Pacific Facial Injectables Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Facial Injectables Market Facts & Figures by Type
8.3 Asia Pacific Facial Injectables Market Facts & Figures by Application
9 Latin America
9.1 Latin America Facial Injectables by Country
9.1.1 Latin America Facial Injectables Sales by Country
9.1.2 Latin America Facial Injectables Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Facial Injectables Market Facts & Figures by Type
9.3 Central & South America Facial Injectables Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Facial Injectables by Country
10.1.1 Middle East and Africa Facial Injectables Sales by Country
10.1.2 Middle East and Africa Facial Injectables Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Facial Injectables Market Facts & Figures by Type
10.3 Middle East and Africa Facial Injectables Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Facial Injectables Products Offered
11.1.5 Allergan Related Developments
11.2 Merz Aesthetics
11.2.1 Merz Aesthetics Corporation Information
11.2.2 Merz Aesthetics Description and Business Overview
11.2.3 Merz Aesthetics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merz Aesthetics Facial Injectables Products Offered
11.2.5 Merz Aesthetics Related Developments
11.3 Prollenium Medical Technologies
11.3.1 Prollenium Medical Technologies Corporation Information
11.3.2 Prollenium Medical Technologies Description and Business Overview
11.3.3 Prollenium Medical Technologies Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Prollenium Medical Technologies Facial Injectables Products Offered
11.3.5 Prollenium Medical Technologies Related Developments
11.4 Bloomega BioTechnology
11.4.1 Bloomega BioTechnology Corporation Information
11.4.2 Bloomega BioTechnology Description and Business Overview
11.4.3 Bloomega BioTechnology Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bloomega BioTechnology Facial Injectables Products Offered
11.4.5 Bloomega BioTechnology Related Developments
11.5 Galderma
11.5.1 Galderma Corporation Information
11.5.2 Galderma Description and Business Overview
11.5.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Galderma Facial Injectables Products Offered
11.5.5 Galderma Related Developments
11.6 Ipsen Group
11.6.1 Ipsen Group Corporation Information
11.6.2 Ipsen Group Description and Business Overview
11.6.3 Ipsen Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ipsen Group Facial Injectables Products Offered
11.6.5 Ipsen Group Related Developments
11.7 Suneva Medical
11.7.1 Suneva Medical Corporation Information
11.7.2 Suneva Medical Description and Business Overview
11.7.3 Suneva Medical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Suneva Medical Facial Injectables Products Offered
11.7.5 Suneva Medical Related Developments
11.8 Polymekon
11.8.1 Polymekon Corporation Information
11.8.2 Polymekon Description and Business Overview
11.8.3 Polymekon Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Polymekon Facial Injectables Products Offered
11.8.5 Polymekon Related Developments
11.9 Visionmed
11.9.1 Visionmed Corporation Information
11.9.2 Visionmed Description and Business Overview
11.9.3 Visionmed Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Visionmed Facial Injectables Products Offered
11.9.5 Visionmed Related Developments
11.10 Syneron
11.10.1 Syneron Corporation Information
11.10.2 Syneron Description and Business Overview
11.10.3 Syneron Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Syneron Facial Injectables Products Offered
11.10.5 Syneron Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Facial Injectables Products Offered
11.1.5 Allergan Related Developments
11.12 AQTIS Medical
11.12.1 AQTIS Medical Corporation Information
11.12.2 AQTIS Medical Description and Business Overview
11.12.3 AQTIS Medical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 AQTIS Medical Products Offered
11.12.5 AQTIS Medical Related Developments
11.13 ColBar LifeScience
11.13.1 ColBar LifeScience Corporation Information
11.13.2 ColBar LifeScience Description and Business Overview
11.13.3 ColBar LifeScience Sales, Revenue and Gross Margin (2015-2020)
11.13.4 ColBar LifeScience Products Offered
11.13.5 ColBar LifeScience Related Developments
11.14 SciVision Biotech
11.14.1 SciVision Biotech Corporation Information
11.14.2 SciVision Biotech Description and Business Overview
11.14.3 SciVision Biotech Sales, Revenue and Gross Margin (2015-2020)
11.14.4 SciVision Biotech Products Offered
11.14.5 SciVision Biotech Related Developments
11.15 Hangzhou Techderm Biological Products
11.15.1 Hangzhou Techderm Biological Products Corporation Information
11.15.2 Hangzhou Techderm Biological Products Description and Business Overview
11.15.3 Hangzhou Techderm Biological Products Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Hangzhou Techderm Biological Products Products Offered
11.15.5 Hangzhou Techderm Biological Products Related Developments
11.16 Qufu Guanglong Biochem
11.16.1 Qufu Guanglong Biochem Corporation Information
11.16.2 Qufu Guanglong Biochem Description and Business Overview
11.16.3 Qufu Guanglong Biochem Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Qufu Guanglong Biochem Products Offered
11.16.5 Qufu Guanglong Biochem Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Facial Injectables Market Estimates and Projections by Region
12.1.1 Global Facial Injectables Sales Forecast by Regions 2021-2026
12.1.2 Global Facial Injectables Revenue Forecast by Regions 2021-2026
12.2 North America Facial Injectables Market Size Forecast (2021-2026)
12.2.1 North America: Facial Injectables Sales Forecast (2021-2026)
12.2.2 North America: Facial Injectables Revenue Forecast (2021-2026)
12.2.3 North America: Facial Injectables Market Size Forecast by Country (2021-2026)
12.3 Europe Facial Injectables Market Size Forecast (2021-2026)
12.3.1 Europe: Facial Injectables Sales Forecast (2021-2026)
12.3.2 Europe: Facial Injectables Revenue Forecast (2021-2026)
12.3.3 Europe: Facial Injectables Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Facial Injectables Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Facial Injectables Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Facial Injectables Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Facial Injectables Market Size Forecast by Region (2021-2026)
12.5 Latin America Facial Injectables Market Size Forecast (2021-2026)
12.5.1 Latin America: Facial Injectables Sales Forecast (2021-2026)
12.5.2 Latin America: Facial Injectables Revenue Forecast (2021-2026)
12.5.3 Latin America: Facial Injectables Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Facial Injectables Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Facial Injectables Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Facial Injectables Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Facial Injectables Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Facial Injectables Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Facial Injectables Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Facial Injectables Market Segments
Table 2. Ranking of Global Top Facial Injectables Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Facial Injectables Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Botox
Table 5. Major Manufacturers of Dermal Fillers
Table 6. Major Manufacturers of Other
Table 7. Global Facial Injectables Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Facial Injectables Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Facial Injectables Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Facial Injectables Sales Market Share by Regions (2015-2020)
Table 11. Global Facial Injectables Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Facial Injectables Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Facial Injectables Sales Share by Manufacturers (2015-2020)
Table 14. Global Facial Injectables Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Facial Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Facial Injectables as of 2019)
Table 16. Facial Injectables Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Facial Injectables Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Facial Injectables Price (2015-2020) (USD/Pcs)
Table 19. Facial Injectables Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Facial Injectables Product Type
Table 21. Date of International Manufacturers Enter into Facial Injectables Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Facial Injectables Sales by Type (2015-2020) (K Pcs)
Table 24. Global Facial Injectables Sales Share by Type (2015-2020)
Table 25. Global Facial Injectables Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Facial Injectables Revenue Share by Type (2015-2020)
Table 27. Facial Injectables Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Facial Injectables Sales by Application (2015-2020) (K Pcs)
Table 29. Global Facial Injectables Sales Share by Application (2015-2020)
Table 30. North America Facial Injectables Sales by Country (2015-2020) (K Pcs)
Table 31. North America Facial Injectables Sales Market Share by Country (2015-2020)
Table 32. North America Facial Injectables Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Facial Injectables Revenue Market Share by Country (2015-2020)
Table 34. North America Facial Injectables Sales by Type (2015-2020) (K Pcs)
Table 35. North America Facial Injectables Sales Market Share by Type (2015-2020)
Table 36. North America Facial Injectables Sales by Application (2015-2020) (K Pcs)
Table 37. North America Facial Injectables Sales Market Share by Application (2015-2020)
Table 38. Europe Facial Injectables Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Facial Injectables Sales Market Share by Country (2015-2020)
Table 40. Europe Facial Injectables Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Facial Injectables Revenue Market Share by Country (2015-2020)
Table 42. Europe Facial Injectables Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Facial Injectables Sales Market Share by Type (2015-2020)
Table 44. Europe Facial Injectables Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Facial Injectables Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Facial Injectables Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Facial Injectables Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Facial Injectables Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Facial Injectables Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Facial Injectables Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Facial Injectables Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Facial Injectables Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Facial Injectables Sales Market Share by Application (2015-2020)
Table 54. Latin America Facial Injectables Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Facial Injectables Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Facial Injectables Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Facial Injectables Revenue Market Share by Country (2015-2020)
Table 58. Latin America Facial Injectables Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Facial Injectables Sales Market Share by Type (2015-2020)
Table 60. Latin America Facial Injectables Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Facial Injectables Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Facial Injectables Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Facial Injectables Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Facial Injectables Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Facial Injectables Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Facial Injectables Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Facial Injectables Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Facial Injectables Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Facial Injectables Sales Market Share by Application (2015-2020)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Major Businesses
Table 72. Allergan Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Allergan Product
Table 74. Allergan Recent Development
Table 75. Merz Aesthetics Corporation Information
Table 76. Merz Aesthetics Description and Major Businesses
Table 77. Merz Aesthetics Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Merz Aesthetics Product
Table 79. Merz Aesthetics Recent Development
Table 80. Prollenium Medical Technologies Corporation Information
Table 81. Prollenium Medical Technologies Description and Major Businesses
Table 82. Prollenium Medical Technologies Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Prollenium Medical Technologies Product
Table 84. Prollenium Medical Technologies Recent Development
Table 85. Bloomega BioTechnology Corporation Information
Table 86. Bloomega BioTechnology Description and Major Businesses
Table 87. Bloomega BioTechnology Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Bloomega BioTechnology Product
Table 89. Bloomega BioTechnology Recent Development
Table 90. Galderma Corporation Information
Table 91. Galderma Description and Major Businesses
Table 92. Galderma Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Galderma Product
Table 94. Galderma Recent Development
Table 95. Ipsen Group Corporation Information
Table 96. Ipsen Group Description and Major Businesses
Table 97. Ipsen Group Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Ipsen Group Product
Table 99. Ipsen Group Recent Development
Table 100. Suneva Medical Corporation Information
Table 101. Suneva Medical Description and Major Businesses
Table 102. Suneva Medical Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Suneva Medical Product
Table 104. Suneva Medical Recent Development
Table 105. Polymekon Corporation Information
Table 106. Polymekon Description and Major Businesses
Table 107. Polymekon Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Polymekon Product
Table 109. Polymekon Recent Development
Table 110. Visionmed Corporation Information
Table 111. Visionmed Description and Major Businesses
Table 112. Visionmed Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Visionmed Product
Table 114. Visionmed Recent Development
Table 115. Syneron Corporation Information
Table 116. Syneron Description and Major Businesses
Table 117. Syneron Facial Injectables Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Syneron Product
Table 119. Syneron Recent Development
Table 120. Medytox Corporation Information
Table 121. Medytox Description and Major Businesses
Table 122. Medytox Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Medytox Product
Table 124. Medytox Recent Development
Table 125. AQTIS Medical Corporation Information
Table 126. AQTIS Medical Description and Major Businesses
Table 127. AQTIS Medical Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. AQTIS Medical Product
Table 129. AQTIS Medical Recent Development
Table 130. ColBar LifeScience Corporation Information
Table 131. ColBar LifeScience Description and Major Businesses
Table 132. ColBar LifeScience Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. ColBar LifeScience Product
Table 134. ColBar LifeScience Recent Development
Table 135. SciVision Biotech Corporation Information
Table 136. SciVision Biotech Description and Major Businesses
Table 137. SciVision Biotech Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. SciVision Biotech Product
Table 139. SciVision Biotech Recent Development
Table 140. Hangzhou Techderm Biological Products Corporation Information
Table 141. Hangzhou Techderm Biological Products Description and Major Businesses
Table 142. Hangzhou Techderm Biological Products Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Hangzhou Techderm Biological Products Product
Table 144. Hangzhou Techderm Biological Products Recent Development
Table 145. Qufu Guanglong Biochem Corporation Information
Table 146. Qufu Guanglong Biochem Description and Major Businesses
Table 147. Qufu Guanglong Biochem Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Qufu Guanglong Biochem Product
Table 149. Qufu Guanglong Biochem Recent Development
Table 150. Global Facial Injectables Sales Forecast by Regions (2021-2026) (K Pcs)
Table 151. Global Facial Injectables Sales Market Share Forecast by Regions (2021-2026)
Table 152. Global Facial Injectables Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 153. Global Facial Injectables Revenue Market Share Forecast by Regions (2021-2026)
Table 154. North America: Facial Injectables Sales Forecast by Country (2021-2026) (K Pcs)
Table 155. North America: Facial Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Europe: Facial Injectables Sales Forecast by Country (2021-2026) (K Pcs)
Table 157. Europe: Facial Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Asia Pacific: Facial Injectables Sales Forecast by Region (2021-2026) (K Pcs)
Table 159. Asia Pacific: Facial Injectables Revenue Forecast by Region (2021-2026) (US$ Million)
Table 160. Latin America: Facial Injectables Sales Forecast by Country (2021-2026) (K Pcs)
Table 161. Latin America: Facial Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Middle East and Africa: Facial Injectables Sales Forecast by Country (2021-2026) (K Pcs)
Table 163. Middle East and Africa: Facial Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 165. Key Challenges
Table 166. Market Risks
Table 167. Main Points Interviewed from Key Facial Injectables Players
Table 168. Facial Injectables Customers List
Table 169. Facial Injectables Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Facial Injectables Product Picture
Figure 2. Global Facial Injectables Sales Market Share by Type in 2020 & 2026
Figure 3. Botox Product Picture
Figure 4. Dermal Fillers Product Picture
Figure 5. Other Product Picture
Figure 6. Global Facial Injectables Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Cosmetic Centers
Figure 10. Other
Figure 11. Facial Injectables Report Years Considered
Figure 12. Global Facial Injectables Market Size 2015-2026 (US$ Million)
Figure 13. Global Facial Injectables Sales 2015-2026 (K Pcs)
Figure 14. Global Facial Injectables Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Facial Injectables Sales Market Share by Region (2015-2020)
Figure 16. Global Facial Injectables Sales Market Share by Region in 2019
Figure 17. Global Facial Injectables Revenue Market Share by Region (2015-2020)
Figure 18. Global Facial Injectables Revenue Market Share by Region in 2019
Figure 19. Global Facial Injectables Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Facial Injectables Revenue in 2019
Figure 21. Facial Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Facial Injectables Sales Market Share by Type (2015-2020)
Figure 23. Global Facial Injectables Sales Market Share by Type in 2019
Figure 24. Global Facial Injectables Revenue Market Share by Type (2015-2020)
Figure 25. Global Facial Injectables Revenue Market Share by Type in 2019
Figure 26. Global Facial Injectables Market Share by Price Range (2015-2020)
Figure 27. Global Facial Injectables Sales Market Share by Application (2015-2020)
Figure 28. Global Facial Injectables Sales Market Share by Application in 2019
Figure 29. Global Facial Injectables Revenue Market Share by Application (2015-2020)
Figure 30. Global Facial Injectables Revenue Market Share by Application in 2019
Figure 31. North America Facial Injectables Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Facial Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Facial Injectables Sales Market Share by Country in 2019
Figure 34. North America Facial Injectables Revenue Market Share by Country in 2019
Figure 35. U.S. Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Facial Injectables Market Share by Type in 2019
Figure 40. North America Facial Injectables Market Share by Application in 2019
Figure 41. Europe Facial Injectables Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Facial Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Facial Injectables Sales Market Share by Country in 2019
Figure 44. Europe Facial Injectables Revenue Market Share by Country in 2019
Figure 45. Germany Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Facial Injectables Market Share by Type in 2019
Figure 56. Europe Facial Injectables Market Share by Application in 2019
Figure 57. Asia Pacific Facial Injectables Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Facial Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Facial Injectables Sales Market Share by Region in 2019
Figure 60. Asia Pacific Facial Injectables Revenue Market Share by Region in 2019
Figure 61. China Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Facial Injectables Market Share by Type in 2019
Figure 84. Asia Pacific Facial Injectables Market Share by Application in 2019
Figure 85. Latin America Facial Injectables Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Facial Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Facial Injectables Sales Market Share by Country in 2019
Figure 88. Latin America Facial Injectables Revenue Market Share by Country in 2019
Figure 89. Mexico Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Facial Injectables Market Share by Type in 2019
Figure 96. Latin America Facial Injectables Market Share by Application in 2019
Figure 97. Middle East and Africa Facial Injectables Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Facial Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Facial Injectables Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Facial Injectables Revenue Market Share by Country in 2019
Figure 101. Turkey Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Facial Injectables Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Facial Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Facial Injectables Market Share by Type in 2019
Figure 108. Middle East and Africa Facial Injectables Market Share by Application in 2019
Figure 109. North America Facial Injectables Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Facial Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Facial Injectables Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Facial Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Facial Injectables Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Facial Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Facial Injectables Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Facial Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Facial Injectables Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Facial Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
顔面脂肪移植の世界市場（～2026年） The Facial Fat Transfer is riding a wave of popularity and new advent technologies and procedures are lifted along with it. The market is growing with the rapid pace; mainly due to the increasing demand for facial fat transfer treatments and introduction of advanced technology in the facial rejuvena…- フェイシャルリジュべネーションの世界市場（～2026年） Facial rejuvenation is a combination of cosmetic procedures that are used to restore the youthful appearance to the human face. Growth in the facial rejuvenation market is mainly driven by healthy economic growth witnessed in most countries, leading to rising in disposable income levels and lifestyl…
- 顔面神経麻痺治療の世界市場（～2026年） Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion. The North American facial paralysis market is a gr…
- ジェネリック注射剤の世界市場（～2026年） Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Market Analysis and Insights: Global Generic Injectabl…
- 持続性顔面紅斑治療の世界市場（～2026年） Facial erythema is a very common reason for consulting a dermatologist. While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases. Market Analysis and Insights:…